KALA BIO, Inc.

Biotechnology • Healthcare • Arlington, MA, United States • KALA (NCM)

KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

781 996 5252 1167 Massachusetts Avenue, Arlington, MA 02476, United States

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - Yahoo Finance

Yahoo Finance • Dec 1

Kala Bio Stock Just Plunged 89% Today – Here’s What Happened - Stocktwits

Stocktwits • Sep 29

KALA BIO, Inc. Announces $6 Million Securities Purchase Agreement and Appointment of David E. Lazar as CEO - Quiver Quantitative

Quiver Quantitative • Dec 1

KALA BIO (NASDAQ: KALA) prices $10M registered direct sale of 10M shares at $1.00 - Stock Titan

Stock Titan • Dec 4

What Sparked KALA BIO's Nearly 38% Surge Overnight? - Benzinga

Benzinga • Nov 26

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has KALA BIO, Inc. had layoffs?

No layoff events have been recorded for KALA BIO, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does KALA BIO, Inc. have?

KALA BIO, Inc. has approximately 38 employees.

What industry is KALA BIO, Inc. in?

KALA BIO, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is KALA BIO, Inc. a publicly traded company?

Yes, KALA BIO, Inc. is publicly traded under the ticker symbol KALA on the NCM. The company has a market capitalization of approximately $0.01 billion.

Where is KALA BIO, Inc. headquartered?

KALA BIO, Inc. is headquartered in Arlington, MA, United States at 1167 Massachusetts Avenue, Arlington, MA 02476, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.